Insight Molecular Diagnostics Inc. (OCX) at a glance

Insight Molecular Diagnostics Inc. (OCX) is a micro-cap Healthcare company. It trades at $4.34, with a 39.3% profit margin and revenue decline of 75.8%. It does not pay a dividend. Vestovix scores it 38/100 overall. Its strongest dimension is Value (55/100) and its weakest is Growth (12/100).

Price

$4.34

Market cap

$105.2M

P/E ratio

n/a

Dividend yield

None

Beta

n/a

52-week range

$2.33 to $8.51